Thermo Fisher (TMO) SVP and General Counsel receives new stock and option awards

Rhea-AI Filing Summary

Thermo Fisher Scientific senior vice president and general counsel Thomas B. Shropshire Jr. reported equity awards on common stock and stock options. He received a grant of stock options for 4,281 shares at an exercise price of $0.0000 and a separate award of 978 shares of common stock, both recorded as direct ownership.

The filing notes that the option grant vests in four equal annual installments beginning on February 28, 2027, meaning the right to exercise the full option stretches over four years from that date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Shropshire Thomas B Jr.

Role SVP and General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	4,281	$0.00	--
Grant/Award	Common Stock	978	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 4,281 shares (Direct); Common Stock — 6,057.524 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shropshire Thomas B Jr.

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		978	A	$0	6,057.524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$513.68	02/25/2026		A		4,281		(1)	02/25/2036	Common Stock	4,281	$0	4,281	D

Explanation of Responses:

1. The option vests in four equal annual installments beginning on February 28, 2027.

	/s/ Melodie T. Morin, Attorney-in-Fact for Thomas B. Shropshire, Jr.	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Thermo Fisher (TMO) report for Thomas B. Shropshire Jr.?

Thermo Fisher reported that Thomas B. Shropshire Jr. received equity awards, including 4,281 stock options and 978 shares of common stock. Both awards were recorded as direct ownership and reflect compensation rather than open-market buying or selling activity.

How many stock options were granted to Thermo Fisher (TMO) executive Thomas B. Shropshire Jr.?

Thomas B. Shropshire Jr. was granted stock options covering 4,281 shares of Thermo Fisher common stock. These options were awarded at an exercise price of $0.0000, indicating a compensatory grant rather than a purchase at market value.

When do the newly granted Thermo Fisher (TMO) stock options start vesting?

The option grant to Thomas B. Shropshire Jr. begins vesting on February 28, 2027. According to the filing, the options vest in four equal annual installments starting on that date, spreading full vesting over a four-year period.

What common stock award did Thermo Fisher (TMO) grant to Thomas B. Shropshire Jr.?

Thermo Fisher granted Thomas B. Shropshire Jr. 978 shares of common stock as an equity award. This non-derivative grant is reported as directly owned and represents additional share-based compensation on top of his existing holdings.

What is Thomas B. Shropshire Jr.’s role at Thermo Fisher (TMO) in this Form 4?

In the Form 4, Thomas B. Shropshire Jr. is identified as senior vice president and general counsel of Thermo Fisher Scientific. The reported transactions reflect equity compensation associated with his executive role at the company.

How many Thermo Fisher (TMO) common shares does Thomas B. Shropshire Jr. own after the grant?

Following the reported grant of 978 shares, Thomas B. Shropshire Jr. holds a total of 6,057.524 shares of Thermo Fisher common stock. This total represents his directly owned non-derivative common stock position after the award.